Cidara Therapeutics, Inc. (CDTX) quarterly cash flow statement — complete operating, investing & financing history
| Metric | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 |
|---|
| Cash from Operations | -40.62M | -40.96M | -21.95M | -29.41M | -36.7M | -103.78M | -6.64M | -12.72M | -1.63M | 2.82M | -10.9M | -21M | 27.97M | -11.84M | -23.61M | -14.91M | -11.97M | 3.44M | -1.79M | -11.13M |
| Operating CF Margin % | - | - | - | - | - | -34364.24% | -682.84% | -72.35% | -17.73% | 55.44% | -41.74% | -205.52% | 68.66% | -190.41% | -332.09% | -206.33% | -169.19% | 10.47% | -74.46% | -298.42% |
| Operating CF Growth % | -10.68% | 60.53% | -230.37% | -131.21% | -2145.72% | -3777.53% | 39.03% | 39.42% | -105.84% | 123.84% | 53.84% | -40.89% | 333.65% | -444.07% | -1216.68% | -33.96% | 14.99% | 124.45% | 88.15% | 26.77% |
| Net Income | -83.23M | -25.72M | -23.48M | -52.31M | -12.98M | -89.41M | -10.33M | -5.61M | -9.11M | -12.36M | 3.01M | -13.38M | 14.98M | -13.12M | -18.28M | -16.8M | -18.08M | 10.71M | -18.29M | -21.63M |
| Depreciation & Amortization | 28K | 27K | 49K | 59K | 61K | 57K | 56K | 39K | 22K | -263K | 32K | 315K | 310K | 303K | 297K | -1.42M | 292K | 266K | 40K | 45K |
| Stock-Based Compensation | 3.17M | 2.96M | 1.74M | 1.66M | 751K | 703K | 795K | 830K | 796K | 795K | 640K | 673K | 843K | 678K | 1.34M | 1.36M | 901K | 871K | 879K | 847K |
| Deferred Taxes | 0 | 5.51M | -5.51M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -523K | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 160K | -9.13M | 422K | 307K | -2.7M | 460K | 220K | 2.69M | 269K | 229K | 737K | -1.77M | 1.77M | 523K | 1K | 3K | 2K | 6K | 4K | 4K |
| Working Capital Changes | 39.26M | -14.6M | 4.83M | 20.87M | -21.82M | -15.59M | 2.61M | -10.67M | 6.39M | 14.42M | -15.32M | -6.84M | 10.07M | 302K | -6.96M | 1.95M | 4.92M | -8.41M | 15.58M | 9.61M |
| Change in Receivables | -2K | -165K | 0 | 5K | 650K | 4.66M | 8.96M | -13.07M | 2.31M | 20.34M | -20.29M | -791K | -210K | 3.95M | -3.43M | -1.48M | -715K | -3.15M | 11.16M | -9.24M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 7.27M | -1.17M | -3.2M | -513K | -1.95M | 0 | 0 | 554K | 1.14M | -657K | 1.4M | 0 | 0 | 461K | -583K |
| Change in Payables | 63.56M | -12.59M | 7.78M | 5.42M | 3.16M | -4.73M | -4.85M | 2.68M | 3.33M | -246K | 3.19M | -2.37M | -554K | -1.14M | 657K | -1.09M | 0 | 0 | -253K | 6.59M |
| Cash from Investing | -176.47M | 0 | 185K | 0 | -106K | 0 | -23K | -178K | -126K | -107K | -94K | -9K | -9K | -16K | -84K | 0 | -12K | -17K | -12K | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | -106K | 0 | -23K | -178K | -126K | -107K | -94K | -9K | -9K | -16K | -84K | 0 | -12K | -17K | -12K | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | 2.36% | 1.01% | 1.37% | 2.1% | 0.36% | 0.09% | 0.02% | 0.26% | 1.18% | - | 0.17% | 0.05% | 0.5% | - |
| Acquisitions | 0 | 0 | 185K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -176.47M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | 160K | 383.38M | 77K | 98.2M | -182K | 239.13M | -93K | 8K | 0 | -261K | 26.24M | 664K | 107K | -1.11M | -611K | 36.88M | -810K | 887K | 7.64M | 409K |
| Debt Issued (Net) | 0 | 0 | -50K | -76K | -75K | -75K | -50K | 0 | 0 | 0 | 0 | 0 | -371K | -1.11M | -1.11M | -1.11M | -1.11M | -1.11M | -1.11M | -1.11M |
| Equity Issued (Net) | -1000K | 1000K | 127K | 1000K | -107K | 1000K | -4K | 1K | 0 | -261K | 1000K | 664K | 1000K | 0 | 500K | 1000K | 301K | 1000K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 1.38M | 137K | 0 | 46K | 0 | 4K | -39K | 7K | 0 | 0 | 14K | 0 | -720K | 0 | 0 | 0 | 0 | 5K | 1K | 0 |
| Net Change in Cash | -216.93M | 342.42M | -21.69M | 68.79M | -36.98M | 135.35M | -6.76M | -12.89M | -1.76M | 2.45M | 15.24M | -20.35M | 28.07M | -12.96M | -24.3M | 21.97M | -12.79M | 4.31M | 5.84M | -10.72M |
| Free Cash Flow | -40.62M | -40.96M | -21.95M | -29.41M | -36.8M | -103.78M | -6.67M | -12.9M | -1.76M | 2.71M | -10.99M | -21.01M | 27.96M | -11.85M | -23.69M | -14.91M | -11.98M | 3.42M | -1.8M | -11.13M |
| FCF Margin % | - | - | - | - | - | -34364.24% | -685.2% | -73.37% | -19.1% | 53.34% | -42.1% | -205.61% | 68.63% | -190.67% | -333.27% | -206.33% | -169.36% | 10.42% | -74.96% | -298.42% |
| FCF Growth % | -10.36% | 60.53% | -229.23% | -128.02% | -1990.97% | -3922.47% | 39.35% | 38.6% | -106.29% | 122.91% | 53.6% | -40.95% | 333.34% | -446.25% | -1212.58% | -33.96% | 15.23% | 124.16% | 88.1% | 26.77% |
| FCF per Share | -2.61 | -2.63 | -1.55 | -3.02 | -5.64 | -22.74 | -1.47 | -2.85 | -0.39 | 0.60 | -2.17 | -5.84 | 6.31 | -3.43 | -6.95 | -4.62 | -4.84 | 1.15 | -0.77 | -5.04 |
| FCF Conversion (FCF/Net Income) | 0.49x | 1.59x | 0.93x | 0.56x | 2.30x | 1.14x | 0.64x | 2.27x | 0.18x | -0.21x | -3.62x | 1.57x | 1.87x | 0.90x | 1.29x | 0.89x | 0.66x | 0.32x | 0.10x | 0.51x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 51K | 64K | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 146K | 63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |